| ALN | Program Name | Expenditures |
|---|---|---|
| 93.RD | Influenza Reagent Resource (2) | $23.02M |
| 93.RD | Microbiology and Infectious Diseases Biological Resource Repository | $20.96M |
| 93.RD | Central Repository - Pass-Through Award | $8.53M |
| 93.RD | Reagent Program for Hiv and Other Infectious Diseases | $3.60M |
| 93.RD | Biological and Emerging Infections Research Resources Program | $3.29M |
| 93.855 | High Containment Facility Renovations – Pandemic Preparedness | $2.27M |
| 93.360 | Barda Bsip Idiq | $1.44M |
| 93.RD | In Vitro Assessment of Antimicrobial Activity | $932,873 |
| 10.001 | Nbaf-Biorepository Transfer Support – Direct Award | $838,144 |
| 93.RD | Molecular Epidemiology Assay Support – Direct Award | $158,170 |
| 12.351 | Early Growth Response Factor 1 Regulation of Neuronal Survival Inflammation – Pass-Through Award | $126,938 |
| 93.RD | Comprehensive and Rapid Response Research Program | $122,052 |
| 93.RD | Labskin Model Data Acquisition – Direct Award | $72,138 |
| 93.RD | Stabilizing Flavivirus Rna Gentegra | $35,075 |
| 12.351 | Genome-Wide Mapping of Host Proteome – Direct Award | $18,235 |
| 93.855 | Generation of Mutants of Mycobacterium Tuberculosis | $13,233 |